May 04, 2020
Coronavirus Disease 2019 (COVID-19) Global Clinical Trials Review, H1, 2020
May 01, 2020
Premier Research Recognized as a Top CRO By Life Science Leader
May 01, 2020
TriNetX Taps Cohort of 66,700 Patients, Finds More Stroke Victims Among COVID-19 Patients Aged 30-50
Apr 28, 2020
BerGenBio's Bemcentinib Selected to Be Fast-tracked As Potential Treatment for COVID-19 Through New National UK Government Clinical Trial Initiative
Apr 28, 2020
Key Pipeline Products for the Global Community Acquired Infections Sector: Emerging Therapies by Clinical Trial Stage
Apr 22, 2020
Aetion and HealthVerity Launch Integrated Real-World Evidence Solution to Assess the Safety and Effectiveness of COVID-19 Interventions
Apr 21, 2020
Science 37® Partners with Advarra to Expedite Virtual Trial Research for COVID-19
Apr 20, 2020
Advarra Acquires IRBco
Apr 18, 2020
NW Bio To Discuss Projected Schedule For Data Lock, Unblinding and Top Line Data From Its Phase 3 Clinical Trial At Annual Shareholder Meeting
Apr 16, 2020
Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2020
Apr 16, 2020
Glaucoma Global Clinical Trials Review, H1, 2020
Apr 16, 2020
Hepatitis B Global Clinical Trials Review, H1, 2020
Apr 16, 2020
Schizoaffective Disorder Global Clinical Trials Review, H1, 2020
Apr 16, 2020
COVID-19 Clinical Trial Pipeline Study 2020: Clinical Trial Stages, Drug Mechanism Classes, Companies, Short-term Launch Highlights
Apr 16, 2020
Female Contraception Global Clinical Trials Review, H1, 2020
Apr 15, 2020
PanAmerican Clinical Research and CAIMED Announce Strategic Latin American Clinical Site Alliance and New Combined Research Center in Brownsville, TX
Apr 14, 2020
Nucleus Network's 10 Step Guide to conducting Clinical Trials during a time of uncertainty
Apr 13, 2020
Proteostasis Therapeutics Announces Completion of Scientific Advice Meeting with the Dutch Medicines Evaluation Board
Apr 09, 2020
nCoup Makes IDS Free for COVID-19 Studies
Apr 06, 2020
BioMarin Plans Regulatory Submissions for Marketing Authorization of Vosoritide to Treat Children with Achondroplasia in 3Q 2020 in both US and Europe